Heparesc (human heterologous liver cells)
Orphan
- Region
- 🇪🇺 EU
- Active substance
- human heterologous liver cells
- Company
- Cytonet GmbH KG
- Status
- Refused
- Therapeutic area
- Urea Cycle Disorders, Inborn
- CHMP opinion
- Thu 22 Oct 2015
- Designations
- Orphan
- Application
- EMEA/H/C/003750
- ATC
- A16
- Official record
- www.ema.europa.eu
Indication
Treatment of urea cycle disorders (UCD).
Regulatory milestones
No milestones recorded in the last year.
Follow Heparesc
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.